Heron Therapeutics Inc

NASDAQ:HRTX 4:00:00 PM EDT

2.77

-0.16 (-5.46%)

6:45:59 PM EDT: $2.77 0.00 (0.00%)

Market Cap (Intraday)	416.41M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$32.8 Million
Adjusted EPS	-$0.07

See more estimates

10-Day MA	$2.83
50-Day MA	$2.72
200-Day MA	$1.74

See more pivots

Heron Therapeutics Inc Stock, NASDAQ:HRTX

4242 Campus Point Court, Suite 200, San Diego, California 92121

United States of America

Phone: +1.858.251.4400

Number of Employees: 126

http://www.herontx.com

Description

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.